Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON38526Recruiting
Randomised, double-blind trial in breast cancer comparing Dobutamine intraoperative + postoperative placebo, Dobutamine intraoperative + postoperative dobutamine and Placebo intraoperative + postoperative placebo (3 arms). Primary endpoint: Increase in blood flow. Started Nov 2013; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON38526.